291 related articles for article (PubMed ID: 26135623)
1. The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.
Poleszak E; Szopa A; Wyska E; Wośko S; Serefko A; Wlaź A; Pieróg M; Wróbel A; Wlaź P
Life Sci; 2015 Sep; 136():13-8. PubMed ID: 26135623
[TBL] [Abstract][Full Text] [Related]
2. Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.
Stasiuk W; Szopa A; Serefko A; Wyska E; Świąder K; Dudka J; Wlaź P; Poleszak E
J Neural Transm (Vienna); 2017 Mar; 124(3):387-396. PubMed ID: 27900470
[TBL] [Abstract][Full Text] [Related]
3. Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice.
Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
Pharmacol Biochem Behav; 2012 Dec; 103(2):273-8. PubMed ID: 22940586
[TBL] [Abstract][Full Text] [Related]
4. Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice.
Szopa A; Poleszak E; Wyska E; Serefko A; Wośko S; Wlaź A; Pieróg M; Wróbel A; Wlaź P
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):211-21. PubMed ID: 26614569
[TBL] [Abstract][Full Text] [Related]
5. The influence of selective A1 and A2A receptor antagonists on the antidepressant-like activity of moclobemide, venlafaxine and bupropion in mice.
Bogatko K; Poleszak E; Szopa A; Wyska E; Wlaź P; Świąder K; Wlaź A; Doboszewska U; Rojek K; Serefko A
J Pharm Pharmacol; 2018 Sep; 70(9):1200-1208. PubMed ID: 29943503
[TBL] [Abstract][Full Text] [Related]
6. Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice.
Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Świąder K; Wróbel A; Szponar J; Doboszewska U; Wlaź P; Wlaź A; Serefko A
Pharmacol Rep; 2020 Dec; 72(6):1562-1572. PubMed ID: 32221841
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Kumar A; Garg R; Gaur V; Kumar P
Brain Res; 2010 Jan; 1311():73-80. PubMed ID: 19945444
[TBL] [Abstract][Full Text] [Related]
8. Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.
Bortolatto CF; Jesse CR; Wilhelm EA; Nogueira CW
Life Sci; 2010 Feb; 86(9-10):372-6. PubMed ID: 20102723
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.
Kale PP; Addepalli V
Pharmacol Biochem Behav; 2014 Sep; 124():238-44. PubMed ID: 24933334
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
11. The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice.
Wróbel A; Serefko A; Wlaź P; Poleszak E
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():243-8. PubMed ID: 24984273
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice.
Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):121-6. PubMed ID: 22406168
[TBL] [Abstract][Full Text] [Related]
13. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
Dhir A; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):921-5. PubMed ID: 17379375
[TBL] [Abstract][Full Text] [Related]
14. Interaction between venlafaxine and caffeine on antinociception in mice.
Yaba G; Sezer Z; Tekol Y
Pharmazie; 2006 Jan; 61(1):60-2. PubMed ID: 16454208
[TBL] [Abstract][Full Text] [Related]
15. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Dhir A; Kulkarni SK
Neurosci Lett; 2007 Jun; 420(3):204-8. PubMed ID: 17532136
[TBL] [Abstract][Full Text] [Related]
16. Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?
Prica C; Hascoet M; Bourin M
Behav Brain Res; 2008 Dec; 194(1):92-9. PubMed ID: 18647622
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice.
Poleszak E; Wlaź P; Szewczyk B; Kedzierska E; Wyska E; Librowski T; Szymura-Oleksiak J; Fidecka S; Pilc A; Nowak G
Pharmacol Biochem Behav; 2005 Jul; 81(3):524-9. PubMed ID: 15936065
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
Krass M; Wegener G; Vasar E; Volke V
Behav Brain Res; 2011 Mar; 218(1):57-63. PubMed ID: 21093491
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.
Nowakowska E; Kus K
Arzneimittelforschung; 2005; 55(3):153-9. PubMed ID: 15819387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
